0 citations0 references

The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria

Allergy2018Vol. 73(7), pp. 1393–1414

Citations Over TimeTop 1% of 2018 papers

Torsten Zuberbier, Werner Aberer, Riccardo Asero, Amir Hamzah Abdul Latiff, Donald R Baker, Barbara Ballmer‐Weber, Jonathan A. Bernstein, Carsten Bindslev‐Jensen, Zenon Brzoza, Roberta Buense Bedrikow, Giorgio Walter Canonica, Martin K. Church, Timothy Craig, I V Danilycheva, Corinna Dressler, Luís Felipe Ensina, Ana M. Giménez‐Arnau, Kiran Godse, Margarida Gonçalo, Clive Grattan, Jean‐Louis Hébert, Michihiro Hide, Allen P. Kaplan, Alexander Kapp, Constance H. Katelaris, Emek Kocatürk, Kanokvalai Kulthanan, Désirée Larenas‐Linnemann, T.A. Leslie, Markus Magerl, P. Mathelier‐Fusade, Raisa Meshkova, Martin Metz, Alexander Nast, Eustachio Nettis, Hanneke Oude‐Elberink, Stefanie Rosumeck, Sarbjit S. Saini, Mario Sánchez‐Borges, Peter Schmid‐Grendelmeier, Petra Staubach, Gordon Sussman, Elias Toubi, Gino Antonio Vena, Christian Vestergaard, Bettina Wedi, Ricardo Niklas Werner, Zuotao Zhao, Marcus Maurer, Endorsed by the following societies: AAAAI, AAD, AAIITO, ACAAI, AEDV, APAAACI, ASBAI, ASCIA, BAD, BSACI, CDA, CMICA, CSACI, DDG, DDS, DGAKI, DSA, DST, EAACI, EIAS, EDF, EMBRN, ESCD, GA²LEN, IAACI, IADVL, JDA, NVvA, MSAI, ÖGDV, PSA, RAACI, SBD, SFD, SGAI, SGDV, SIAAIC, SIDeMaST, SPDV, TSD, UNBB, UNEV and WAO

Abstract

This evidence- and consensus-based guideline was developed following the methods recommended by Cochrane and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group. The conference was held on 1 December 2016. It is a joint initiative of the Dermatology Section of the European Academy of Allergology and Clinical Immunology (EAACI), the EU-founded network of excellence, the Global Allergy and Asthma European Network (GA²LEN), the European Dermatology Forum (EDF) and the World Allergy Organization (WAO) with the participation of 48 delegates of 42 national and international societies. This guideline was acknowledged and accepted by the European Union of Medical Specialists (UEMS). Urticaria is a frequent, mast cell-driven disease, presenting with wheals, angioedema, or both. The lifetime prevalence for acute urticaria is approximately 20%. Chronic spontaneous urticaria and other chronic forms of urticaria are disabling, impair quality of life and affect performance at work and school. This guideline covers the definition and classification of urticaria, taking into account the recent progress in identifying its causes, eliciting factors and pathomechanisms. In addition, it outlines evidence-based diagnostic and therapeutic approaches for the different subtypes of urticaria.

Citations Over TimeTop 1% of 2018 papers

Abstract

Related Papers